OR WAIT null SECS
July 06, 2022
Will benefit CDMO’s Denmark and Texas locations
With a cost of approximately $514 million, expected completion is 2026
July 01, 2022
Cheshire facility will offer plasmid DNA production, CGT development
June 29, 2022
Marks the CDMO’s second plant in the country
June 23, 2022
Containers to potentially be operational by next year, 2024 at the latest
CDMO looks to combat cancer at lower doses
June 22, 2022
Agency will be reviewing laboratory study and CMC data on the bivalent jab that targets two strains of the SARS-CoV-2 virus
June 21, 2022
CDMO’s Costa Mesa location can start tackling oncology and rare disease treatment
June 20, 2022
Partnership aims to compare reproducibility and comparability between different suspension bioreactors
June 17, 2022
New service offering is GMP compliant, with single-use fermentation capacity of up to 300 L